US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 21.600
  • -1.140-5.01%
Close Apr 25 16:00 ET
  • 21.700
  • +0.100+0.46%
Post 17:53 ET
1.78BMarket Cap-12558P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
10.36%1.19B
10.36%1.19B
-7.23%1.02B
-7.98%1.07B
-13.34%1.06B
11.65%1.08B
11.65%1.08B
17.26%1.09B
89.53%1.17B
142.83%1.22B
-Cash and cash equivalents
87.27%435.9M
87.27%435.9M
8.01%169.05M
-15.09%225.54M
-15.85%249.77M
-58.43%232.77M
-58.43%232.77M
-74.43%156.51M
25.29%265.62M
205.24%296.82M
-Short-term investments
-10.81%753.98M
-10.81%753.98M
-9.77%846.41M
-5.89%847.47M
-12.54%809.7M
108.40%845.37M
108.40%845.37M
191.88%938.04M
123.30%900.49M
127.89%925.78M
Receivables
----
----
----
----
----
----
----
--0
--0
--0
-Accounts receivable
----
----
----
----
----
----
----
--0
--0
--0
Prepaid assets
----
----
----
----
----
----
----
79.05%14.36M
8.35%13.78M
52.09%16.88M
Other current assets
43.39%21.17M
43.39%21.17M
--24.08M
--21.79M
--23.56M
100.57%14.76M
100.57%14.76M
----
----
----
Total current assets
10.81%1.21B
10.81%1.21B
-6.26%1.04B
-7.21%1.09B
-12.62%1.08B
-14.15%1.09B
-14.15%1.09B
17.79%1.11B
74.03%1.18B
140.87%1.24B
Non current assets
Net PPE
1.57%237.81M
1.57%237.81M
5.71%239.66M
8.39%242.28M
19.09%237.98M
25.22%234.13M
25.22%234.13M
29.77%226.71M
31.75%223.52M
25.85%199.83M
-Gross PPE
8.96%287.99M
8.96%287.99M
12.47%284.48M
14.47%281.91M
24.47%272.8M
30.16%264.3M
30.16%264.3M
34.38%252.94M
35.68%246.27M
29.65%219.17M
-Accumulated depreciation
-66.33%-50.18M
-66.33%-50.18M
-70.90%-44.82M
-74.20%-39.63M
-80.08%-34.82M
-87.61%-30.17M
-87.61%-30.17M
-93.95%-26.23M
-92.03%-22.75M
-88.57%-19.33M
Other non current assets
-26.01%10.87M
-26.01%10.87M
-22.51%11.33M
12.26%16.8M
-19.50%11.34M
1.49%14.69M
1.49%14.69M
-7.97%14.62M
-6.43%14.97M
-29.11%14.09M
Total non current assets
-0.06%248.67M
-0.06%248.67M
4.00%250.99M
8.64%259.08M
16.55%249.32M
23.52%248.82M
23.52%248.82M
12.18%241.34M
10.88%238.49M
19.73%213.92M
Total assets
8.79%1.46B
8.79%1.46B
-4.42%1.29B
-4.55%1.35B
-8.33%1.33B
-9.00%1.34B
-9.00%1.34B
16.75%1.35B
58.82%1.42B
109.65%1.45B
Liabilities
Current liabilities
Payables
-82.09%1.62M
-82.09%1.62M
-54.77%3.18M
-2.95%6.89M
124.43%14.06M
20.81%9.03M
20.81%9.03M
-3.54%7.02M
-11.64%7.1M
-21.51%6.27M
-accounts payable
-82.09%1.62M
-82.09%1.62M
-54.77%3.18M
-2.95%6.89M
124.43%14.06M
20.81%9.03M
20.81%9.03M
-3.54%7.02M
-11.64%7.1M
-21.51%6.27M
Current accrued expenses
233.19%61.73M
233.19%61.73M
72.16%23.25M
10.03%20.07M
-53.58%21.13M
-62.22%18.53M
-62.22%18.53M
12.51%13.51M
94.41%18.24M
445.24%45.51M
Current debt and capital lease obligation
23.10%12.78M
23.10%12.78M
21.66%11.95M
20.82%11.49M
19.21%11.16M
37.67%10.38M
37.67%10.38M
51.50%9.82M
172.47%9.51M
140.90%9.36M
-Current capital lease obligation
23.10%12.78M
23.10%12.78M
21.66%11.95M
20.82%11.49M
19.21%11.16M
37.67%10.38M
37.67%10.38M
51.50%9.82M
172.47%9.51M
140.90%9.36M
Current deferred liabilities
-49.47%68.71M
-49.47%68.71M
-4.01%153.48M
-0.39%139.13M
24.07%142.74M
57.61%135.97M
57.61%135.97M
1,147.09%159.9M
1,293.32%139.67M
--115.05M
Other current liabilities
27.47%38.96M
27.47%38.96M
-59.67%14.76M
-23.54%22.03M
-29.64%25.22M
-40.60%30.56M
-40.60%30.56M
-35.74%36.6M
-68.58%28.82M
-55.23%35.84M
Current liabilities
-8.06%205.57M
-8.06%205.57M
-7.74%220.37M
-1.29%209.54M
0.52%219.93M
4.76%223.6M
4.76%223.6M
135.58%238.86M
64.92%212.28M
114.33%218.8M
Non current liabilities
Long term debt and capital lease obligation
-5.17%159.91M
-5.17%159.91M
-2.69%160.64M
-0.08%163.85M
21.51%165.3M
25.08%168.63M
25.08%168.63M
24.00%165.08M
23.49%163.99M
8.11%136.03M
-Long term capital lease obligation
-5.17%159.91M
-5.17%159.91M
-2.69%160.64M
-0.08%163.85M
21.51%165.3M
25.08%168.63M
25.08%168.63M
24.00%165.08M
23.49%163.99M
8.11%136.03M
Non current deferred liabilities
-45.65%109.89M
-45.65%109.89M
-37.14%124.65M
-25.20%156.2M
-23.72%171.71M
-22.92%202.18M
-22.92%202.18M
438.53%198.29M
417.13%208.82M
--225.09M
Other non current liabilities
-78.17%3.02M
-78.17%3.02M
-82.30%5.94M
-61.80%12.66M
-68.67%13.92M
-62.76%13.84M
-62.76%13.84M
6.82%33.55M
-22.31%33.13M
3.52%44.41M
Total non current liabilities
-29.07%272.82M
-29.07%272.82M
-26.63%291.23M
-18.04%332.71M
-13.47%350.92M
-11.43%384.65M
-11.43%384.65M
97.13%396.91M
88.10%405.94M
140.35%405.54M
Total liabilities
-21.35%478.39M
-21.35%478.39M
-19.53%511.59M
-12.29%542.24M
-8.57%570.85M
-6.09%608.24M
-6.09%608.24M
110.01%635.77M
79.44%618.21M
130.54%624.33M
Shareholders'equity
Share capital
14.61%816K
14.61%816K
12.62%794K
10.95%780K
6.59%744K
4.09%712K
4.09%712K
4.14%705K
8.99%703K
13.13%698K
-common stock
14.61%816K
14.61%816K
12.62%794K
10.95%780K
6.59%744K
4.09%712K
4.09%712K
4.14%705K
8.99%703K
13.13%698K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-12.53%-1.19B
-12.53%-1.19B
-30.78%-1.33B
-35.97%-1.24B
-37.77%-1.15B
-37.63%-1.06B
-37.63%-1.06B
-44.84%-1.02B
-34.64%-909.44M
-39.77%-837.49M
Paid-in capital
21.05%2.17B
21.05%2.17B
21.61%2.11B
19.64%2.05B
14.79%1.92B
12.43%1.79B
12.43%1.79B
11.61%1.74B
40.04%1.71B
63.42%1.67B
Gains losses not affecting retained earnings
124.86%604K
124.86%604K
56.70%-2.02M
51.91%-2.02M
71.76%-765K
-4,760.00%-2.43M
-4,760.00%-2.43M
-24,700.00%-4.67M
-13,616.13%-4.19M
-11,187.50%-2.71M
Total stockholders'equity
33.79%981.33M
33.79%981.33M
9.02%778.94M
1.43%811.64M
-8.15%761.51M
-11.28%733.47M
-11.28%733.47M
-16.32%714.48M
45.87%800.16M
96.26%829.07M
Total equity
33.79%981.33M
33.79%981.33M
9.02%778.94M
1.43%811.64M
-8.15%761.51M
-11.28%733.47M
-11.28%733.47M
-16.32%714.48M
45.87%800.16M
96.26%829.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 10.36%1.19B10.36%1.19B-7.23%1.02B-7.98%1.07B-13.34%1.06B11.65%1.08B11.65%1.08B17.26%1.09B89.53%1.17B142.83%1.22B
-Cash and cash equivalents 87.27%435.9M87.27%435.9M8.01%169.05M-15.09%225.54M-15.85%249.77M-58.43%232.77M-58.43%232.77M-74.43%156.51M25.29%265.62M205.24%296.82M
-Short-term investments -10.81%753.98M-10.81%753.98M-9.77%846.41M-5.89%847.47M-12.54%809.7M108.40%845.37M108.40%845.37M191.88%938.04M123.30%900.49M127.89%925.78M
Receivables ------------------------------0--0--0
-Accounts receivable ------------------------------0--0--0
Prepaid assets ----------------------------79.05%14.36M8.35%13.78M52.09%16.88M
Other current assets 43.39%21.17M43.39%21.17M--24.08M--21.79M--23.56M100.57%14.76M100.57%14.76M------------
Total current assets 10.81%1.21B10.81%1.21B-6.26%1.04B-7.21%1.09B-12.62%1.08B-14.15%1.09B-14.15%1.09B17.79%1.11B74.03%1.18B140.87%1.24B
Non current assets
Net PPE 1.57%237.81M1.57%237.81M5.71%239.66M8.39%242.28M19.09%237.98M25.22%234.13M25.22%234.13M29.77%226.71M31.75%223.52M25.85%199.83M
-Gross PPE 8.96%287.99M8.96%287.99M12.47%284.48M14.47%281.91M24.47%272.8M30.16%264.3M30.16%264.3M34.38%252.94M35.68%246.27M29.65%219.17M
-Accumulated depreciation -66.33%-50.18M-66.33%-50.18M-70.90%-44.82M-74.20%-39.63M-80.08%-34.82M-87.61%-30.17M-87.61%-30.17M-93.95%-26.23M-92.03%-22.75M-88.57%-19.33M
Other non current assets -26.01%10.87M-26.01%10.87M-22.51%11.33M12.26%16.8M-19.50%11.34M1.49%14.69M1.49%14.69M-7.97%14.62M-6.43%14.97M-29.11%14.09M
Total non current assets -0.06%248.67M-0.06%248.67M4.00%250.99M8.64%259.08M16.55%249.32M23.52%248.82M23.52%248.82M12.18%241.34M10.88%238.49M19.73%213.92M
Total assets 8.79%1.46B8.79%1.46B-4.42%1.29B-4.55%1.35B-8.33%1.33B-9.00%1.34B-9.00%1.34B16.75%1.35B58.82%1.42B109.65%1.45B
Liabilities
Current liabilities
Payables -82.09%1.62M-82.09%1.62M-54.77%3.18M-2.95%6.89M124.43%14.06M20.81%9.03M20.81%9.03M-3.54%7.02M-11.64%7.1M-21.51%6.27M
-accounts payable -82.09%1.62M-82.09%1.62M-54.77%3.18M-2.95%6.89M124.43%14.06M20.81%9.03M20.81%9.03M-3.54%7.02M-11.64%7.1M-21.51%6.27M
Current accrued expenses 233.19%61.73M233.19%61.73M72.16%23.25M10.03%20.07M-53.58%21.13M-62.22%18.53M-62.22%18.53M12.51%13.51M94.41%18.24M445.24%45.51M
Current debt and capital lease obligation 23.10%12.78M23.10%12.78M21.66%11.95M20.82%11.49M19.21%11.16M37.67%10.38M37.67%10.38M51.50%9.82M172.47%9.51M140.90%9.36M
-Current capital lease obligation 23.10%12.78M23.10%12.78M21.66%11.95M20.82%11.49M19.21%11.16M37.67%10.38M37.67%10.38M51.50%9.82M172.47%9.51M140.90%9.36M
Current deferred liabilities -49.47%68.71M-49.47%68.71M-4.01%153.48M-0.39%139.13M24.07%142.74M57.61%135.97M57.61%135.97M1,147.09%159.9M1,293.32%139.67M--115.05M
Other current liabilities 27.47%38.96M27.47%38.96M-59.67%14.76M-23.54%22.03M-29.64%25.22M-40.60%30.56M-40.60%30.56M-35.74%36.6M-68.58%28.82M-55.23%35.84M
Current liabilities -8.06%205.57M-8.06%205.57M-7.74%220.37M-1.29%209.54M0.52%219.93M4.76%223.6M4.76%223.6M135.58%238.86M64.92%212.28M114.33%218.8M
Non current liabilities
Long term debt and capital lease obligation -5.17%159.91M-5.17%159.91M-2.69%160.64M-0.08%163.85M21.51%165.3M25.08%168.63M25.08%168.63M24.00%165.08M23.49%163.99M8.11%136.03M
-Long term capital lease obligation -5.17%159.91M-5.17%159.91M-2.69%160.64M-0.08%163.85M21.51%165.3M25.08%168.63M25.08%168.63M24.00%165.08M23.49%163.99M8.11%136.03M
Non current deferred liabilities -45.65%109.89M-45.65%109.89M-37.14%124.65M-25.20%156.2M-23.72%171.71M-22.92%202.18M-22.92%202.18M438.53%198.29M417.13%208.82M--225.09M
Other non current liabilities -78.17%3.02M-78.17%3.02M-82.30%5.94M-61.80%12.66M-68.67%13.92M-62.76%13.84M-62.76%13.84M6.82%33.55M-22.31%33.13M3.52%44.41M
Total non current liabilities -29.07%272.82M-29.07%272.82M-26.63%291.23M-18.04%332.71M-13.47%350.92M-11.43%384.65M-11.43%384.65M97.13%396.91M88.10%405.94M140.35%405.54M
Total liabilities -21.35%478.39M-21.35%478.39M-19.53%511.59M-12.29%542.24M-8.57%570.85M-6.09%608.24M-6.09%608.24M110.01%635.77M79.44%618.21M130.54%624.33M
Shareholders'equity
Share capital 14.61%816K14.61%816K12.62%794K10.95%780K6.59%744K4.09%712K4.09%712K4.14%705K8.99%703K13.13%698K
-common stock 14.61%816K14.61%816K12.62%794K10.95%780K6.59%744K4.09%712K4.09%712K4.14%705K8.99%703K13.13%698K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -12.53%-1.19B-12.53%-1.19B-30.78%-1.33B-35.97%-1.24B-37.77%-1.15B-37.63%-1.06B-37.63%-1.06B-44.84%-1.02B-34.64%-909.44M-39.77%-837.49M
Paid-in capital 21.05%2.17B21.05%2.17B21.61%2.11B19.64%2.05B14.79%1.92B12.43%1.79B12.43%1.79B11.61%1.74B40.04%1.71B63.42%1.67B
Gains losses not affecting retained earnings 124.86%604K124.86%604K56.70%-2.02M51.91%-2.02M71.76%-765K-4,760.00%-2.43M-4,760.00%-2.43M-24,700.00%-4.67M-13,616.13%-4.19M-11,187.50%-2.71M
Total stockholders'equity 33.79%981.33M33.79%981.33M9.02%778.94M1.43%811.64M-8.15%761.51M-11.28%733.47M-11.28%733.47M-16.32%714.48M45.87%800.16M96.26%829.07M
Total equity 33.79%981.33M33.79%981.33M9.02%778.94M1.43%811.64M-8.15%761.51M-11.28%733.47M-11.28%733.47M-16.32%714.48M45.87%800.16M96.26%829.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday-1.09%